- Home
- CLS vs MEDP Comparison
CLS vs MEDP Comparison
Compare CLS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLS
- MEDP
- Stock Information
- Founded
- CLS 1994
- MEDP 1992
- Country
- CLS Canada
- MEDP United States
- Employees
- CLS N/A
- MEDP N/A
- Industry
- CLS Electrical Products
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CLS Technology
- MEDP Health Care
- Exchange
- CLS Nasdaq
- MEDP Nasdaq
- Market Cap
- CLS 10.4B
- MEDP 11.7B
- IPO Year
- CLS 1998
- MEDP 2016
- Fundamental
- Price
- CLS $92.08
- MEDP $331.00
- Analyst Decision
- CLS Strong Buy
- MEDP Buy
- Analyst Count
- CLS 9
- MEDP 10
- Target Price
- CLS $75.78
- MEDP $389.00
- AVG Volume (30 Days)
- CLS 2.2M
- MEDP 267.5K
- Earning Date
- CLS 01-27-2025
- MEDP 02-10-2025
- Dividend Yield
- CLS N/A
- MEDP N/A
- EPS Growth
- CLS 88.40
- MEDP 33.84
- EPS
- CLS 3.16
- MEDP 11.42
- Revenue
- CLS $9,240,800,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- CLS $21.97
- MEDP $14.01
- Revenue Next Year
- CLS $8.98
- MEDP $5.86
- P/E Ratio
- CLS $30.16
- MEDP $28.98
- Revenue Growth
- CLS 17.52
- MEDP 16.24
- 52 Week Low
- CLS $26.62
- MEDP $277.72
- 52 Week High
- CLS $100.51
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- CLS 56.65
- MEDP 43.26
- Support Level
- CLS $87.83
- MEDP $340.06
- Resistance Level
- CLS $100.51
- MEDP $359.49
- Average True Range (ATR)
- CLS 4.14
- MEDP 10.16
- MACD
- CLS -0.18
- MEDP -0.41
- Stochastic Oscillator
- CLS 50.24
- MEDP 4.04
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.